Doha, August 30 (QNA) - Sidra Medicine, a member of Qatar Foundation, and The Pearl International Hospital have signed an agreement to provide expectant parents with access to Sidra Medicine's cord blood banking services.

The agreement will provide expectant parents the choice to store their baby's umbilical cord blood with Sidra Medicine, as part of their maternity care journey with The Pearl International Hospital. Sidra Medicine will collect, process and store the samples at its specialized GMP facility, which houses Qatar's only Cord Blood Bank. 

Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine, said: "This agreement expands access to an important innovative and specialized service for expectant parents in Qatar. By making clinical-grade cord blood and tissue banking services available to families receiving maternity care at The Pearl International Hospital, we are providing them with the information and support they need to make informed decisions about preserving these valuable biological resources. It also reflects Sidra Medicine's continued commitment to advancing specialized healthcare services for as many patients and families across the country."

Dr. Cem Emir Guldogan, Chief Medical Officer at The Pearl International Hospital, expressed the hospital's pride in this significant achievement, highlighting the hospital's role in providing advanced medical care to the community and reaffirming its continued commitment to enhancing high-quality healthcare services. 

Dr. Guldogan said: "This agreement represents an important milestone in our journey to elevate healthcare standards in the State of Qatar. The Pearl International Hospital has been developed to offer world-class medical expertise, innovative technologies, and an environment that promotes holistic well-being. Our commitment is to provide high-quality, compassionate care that aligns with international best practices while respecting the values of our community." (QNA)